Daniel Shouval
University of Antwerp · 352 works · 17,631 citations · h-index 57
Top works
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- Integration of Hepatitis B Virus DNA into the Genome of Liver Cells in Chronic Liver Disease and Hepatocellular Carcinoma
- Telaprevir for Retreatment of HCV Infection
- Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line
- Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B
- A Controlled Trial of a Formalin-Inactivated Hepatitis A Vaccine in Healthy Children
- p53 mutation in hepatocellular carcinoma after aflatoxin exposure
- Statements from the Taormina expert meeting on occult hepatitis B virus infection
- Hepatitis B vaccines
- Chronic hepatitis in chimpanzee carriers of hepatitis B virus: morphologic, immunologic, and viral DNA studies.
- The global impact of vaccination against hepatitis B: A historical overview
- A Common-Source Outbreak of Fulminant Hepatitis B in a Hospital
- Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies
- Detection and characterization of hepatitis B virus DNA in serum of HBe antigen‐negative HBsAg carriers
- Hepatitis A booster vaccination: is there a need?
- Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers
- Hepatocellular carcinoma
- Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention
- Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis
- Relapsing Hepatitis A Review of 14 Cases and Literature Survey